Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Legal & Regulatory Features & News

Image created by RRY Publications, LLC / Source: Napoleon Bonaparte and Wikimedia Commons
Image created by RRY Publications, LLC / Source: Napoleon Bonaparte and Wikimedia Commons

Alphatec’s $49 Million French Adventure

When Healthpoint Capital merged Alphatec and Scient’X in 2006, it stuck its finger into a festering litigation involving French spine companies, secret deals and a French doctor in Beverly Hills. When the dust settled, Alphatec agreed to pay $49 million to lance the boil. Is it over? Read here.

Advertisement

Infuse Off-Label Lawsuits Begin

Image crated by RRY Publications, LLC / Source: Wikimedia Commons
Image crated by RRY Publications, LLC / Source: Wikimedia Commons

No product has generated more questions about off-label use than Medtronic’s Infuse. From The Spine Journal to the U.S. Senate, partisan advocates have vilified Medtronic for their promotion of the product. Now the lawsuits have started and patients are claiming harm because Medtronic promoted off-label uses. Read what one patient has to say.

Advertisement
Advertisement
Advertisement
Advertisement